MAPK1 and Parkinson disease: Third, combinatorial strategies that simultaneously target BDNF–ERK signaling and intersecting pathways, such as PI3K/Akt, JNK, and p38MAPK, may offer synergistic neuroprotection, particularly in multifactorial conditions like AD and PD.